Endovascular treatment of recurring type A dissection after total aortic arch debranching

Standard treatment method of the aortic arch pathologies is surgical replacement which requires cardiopulmonary bypass and deep hypothermic circulatory arrest. However, this approach is associated with major operative risks. Combination of debranching and thoracic endovascular aortic arch repair (TE...

Full description

Saved in:
Bibliographic Details
Published inCardiovascular intervention and therapeutics Vol. 30; no. 3; pp. 273 - 276
Main Authors Ozcan, Turkay, Celik, Ahmet, Karaca, Kerem, Ozeren, Murat
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.07.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Standard treatment method of the aortic arch pathologies is surgical replacement which requires cardiopulmonary bypass and deep hypothermic circulatory arrest. However, this approach is associated with major operative risks. Combination of debranching and thoracic endovascular aortic arch repair (TEVAR) has emerged as an alternative treatment modality in high-risk patients. This report describes successful staged hybrid treatment of a 50-year-old male patient with recurring type A dissection. It is concluded that staged debranching and TEVAR is a feasible option and provides aortic repair without increase of risk.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1868-4300
1868-4297
DOI:10.1007/s12928-014-0278-0